The conference is organised by Aniridia Bulgaria in collaboration with the Bulgarian Society of Ophthalmology, Aniridia Europe, and Arbilis.
Aniridia Bulgaria
Aniridia Bulgaria is hosting an event with several key objectives:
– Support and unify individuals with aniridia.
– Enhance training for researchers and healthcare professionals.
– Raise public awareness about the disease and its effects.
– Promote aniridia research locally and internationally.
– Connect with similar organisations and government bodies.
– Address emotional impacts and support social rehabilitation.
– Fund treatment and assistance for those affected by aniridia.
Read more about Aniridia Bulgaria.
Bulgarian Society of Ophthalmology
The society’s activities include:
– Improving diagnosis, prevention, and treatment of eye diseases in Bulgaria and globally.
– Participating in national and international events and projects.
– Organizing seminars, conferences, and training on new technologies in ophthalmology.
– Preparing analyses, strategies, and proposals for regulatory amendments in ophthalmology.
– Building relationships between medical and patient organisations to promote a healthy culture.
– Collaborating with other organisations aligned with the society’s goals.
– Providing training for residents and specialists to enhance their qualifications and support young talent.
– Promoting modern achievements in ophthalmology among healthcare professionals.
– Publishing specialised literature and the “Bulgarian Ophthalmological Review.”
– Assessing needs and achievements in ophthalmology to strategise for future development.
Read more about Bulgarian Society of Ophthalmology
Aniridia Europe
– Collaborate to disseminate accurate information about aniridia and the best available treatments.
– Support and inspire research by fostering scientific interest in aniridia and related conditions.
– Connect professionals at both local and international levels.
– Promote the development of national and international guidelines for aniridia.
– Encourage individuals affected by aniridia to establish associations in other countries..
Scientific committee
Professor CN Grupcheva (Chair)
MD, PhD, DSc, FEBO, FICO (Hon), FBCLA, FIACLE
Corresponding member of Bulgarian Academy of Sciences
Evlogi Georgiev 4, Varna, Bulgaria
Prof. Dr CN Grupcheva, MD, PhD, FEBO, FICO, FIACLE, FBCLA, is a Bulgarian medical doctor, specialist in ophthalmology since 1996. She continued her studies with short fellowships at Moorfields Eye Hospital, London and Dundee University, UK. In 2000, she relocated to New Zealand as a Senior Research Fellow at Auckland University for three years. During that period, she completed a PhD with high commendations and Best Doctorial Thesis Prize of Auckland University for 2002. She relocated to her home country to serve as a high-level academic and medical director. During her career, she served as a Head of ophthalmology department for 12 years and Vice Recor for 10. She is a corresponding member of the Bulgarian Academy of Science and an active member of esteemed learned societies, such as Academia Ophthalmologica Internationalis, European Society of Cataract and Refractive Surgery (elected council member) and more. She has published more than 180 scientific papers and 17 ophthalmology books. She has Hi index of 48 and more than 3000 citations. Professor Grupcheva teaches at all graduate and postgraduate levels and is/was a supervisor of 28 PhD students and 22 residents in ophthalmology. She is the past president of the European Board of Ophthalmology and current President of Bulgarian Ophthalmological Society. Currently, she serves as TFOS ambassador for Bulgaria.

Professor Dominique Bremond-Gignac
MD, PhD, FEBO, Professor of Ophthalmology, University Hospital Necker Enfants Malades, Paris, France
Dominique BREMOND-GIGNAC, MD, PhD, FEBO, is Professor of Ophthalmology, Head of Ophthalmology Department with pediatric ophthalmology subspecialties at University Hospital Necker-Enfants malades and Paris Cité University in Paris. Head of Paris Orthoptic Department, affiliated to INSERM UMRS 1138, Team 17 Research Unit, in innovation therapy. Her activity is distributed in clinical practice, teaching and research. Current practice mainly in children, includes rare eye diseases as well in congenital aniridia. Chair of Aniridia Europe and of Geniris French Association. She contributed over two hundred and fifty peer review publications in the ophthalmic literature and more than fifty books or books chapters. In april 2019 she received for a lecture Al Biglan Medal Distinction from Pittsburgh University (UPMC). Involved in visual health in children she is Executive member of WSPOS (World Strabismus and Pediatric Ophthalmology Society) and President Elect 2021 of EVER (European Association for Vision and Eye Research). Decorated by French Ministry of “Ordre de la Legion d’Honneur” and “Ordre des Palmes Académiques”. President of EuMyS European Myopia Society. Head of CLAIROP Research Clinical Center accredited by Europe EVI-CR and Head of OPHTARA Rare Eye Diseases Center accredited by French Health Ministry and ERN EYE (Europe).
Professor Neil Lagali
Full Professor of Experimental Ophthalmology at Linköping University, Sweden, Linköping
Neil Lagali is full Professor of Experimental Ophthalmology at Linköping University, Sweden, where he leads a team of researchers focusing on the genetic and molecular basis of common and rare eye diseases with a special interest in aniridia and aniridia-associated keratopathy (AAK), performing research in this area for over 15 years. The team’s focus is to better understand the genetic, molecular, and physiological origins of AAK and to develop new pharmacotherapies. He has led large European consortia such as the EU COST Action ANIRIDIA-NET and has examined the corneas of aniridia patients in many European countries. He currently has over 150 publications in the field of eye research.
Professor Dr Szentmáry Nóra
Homburg, Germany, Dr Rolf M. Schwiete Centre for Limbal Stem Cell and Congenital Aniridia Research, Saarland University
Prof. Szentmáry was born in Budapest and studied medicine at Semmelweis University, where she qualified as an ophthalmologist and earned her PhD in 2005. From 2008 to 2010, supported by an Alexander von Humboldt Fellowship, she continued her research at the Universities of Erlangen-Nuremberg and Saarland in Germany. She completed her habilitation at the Saarland University Medical Faculty in 2012. Her clinical and scientific work focuses primarily on corneal, ocular surface, and anterior segment diseases. She has authored 11 book chapters and 310 scientific publications to date and has successfully supervised 10 Ph.D. theses. Fifty of her publications address clinical or basic research on congenital aniridia. Since June 2020, she has been working as head of the Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research in Homburg/Saar. She has also been Head of the Cornea and Ocular Surface Section of the European Association for Vision and Eye Research (EVER) between 2017-2022. Between 2022-2023 she was President of the EVER, and she received the title EVER Felow and honorary life member of EVER in 2023. She is editor of Journal of Ophthalmology, Biomolecules, Acta Ophthalmologica Scandinavica, Ophthalmology and Therapy and Current Eye Research. Professor Szentmáry speaks English, German, French and Spanish besides her mother tongue.

Professor Vito Romano
Brescia, Italy, University of Brescia
Vito Romano is passionate about translational research and clinical trial design, with a special interest in cornea, cataract, and refractive surgery, ophthalmic imaging, and ocular surface diseases. He is Professor of Ophthalmology at University of Brescia (Italy) with an honorary position at the University of Liverpool.
Cooperation, support and sponsors
This conference would not be possible without the kind and generous support and cooperation of our partners and donors.
About previous European Aniridia Conferences
The European Aniridia Conference (EAC) takes place every two years in a different European city. It is usually organised jointly by the national aniridia association and a prominent health institution.







